Introduction {#s1}
============

Ginseng, a valuable Chinese herb, has been used in China, Korea, and other oriental countries for thousands of years ([@B8]). In recent years, a large number of studies have demonstrated its efficacy in improving immunity ([@B17]), enhancing memory ([@B24]), improving cardiovascular function ([@B11]; [@B25]), anti-tumor ([@B8]), and delaying aging ([@B26]; [@B19]). Ginsenoside, a kind of glycoside compounds composed of glycogen and glucose, is widely regarded as the main active ingredient of ginseng ([@B6]), because they have its own function similar to ginseng's pharmaceutical function, such as anti-inflammation ([@B2]; [@B23]), anti-tumor, and anti-aging effects, which have been shown in a series of studies *in vitro* and *in vivo*.

Most ginsenosides have low bioavailability ([@B22]). After ingestion, some ginsenosides, such as Rb1, the most abundant ginsenoside, are metabolized into smaller molecules in the gastrointestinal tract through hydrolysis and then absorbed by the intestine ([@B5]). Most ginsenosides were directly discharged from the body due to their high molecular weight and poor transmittance of mucous membrane ([@B1]; [@B13]). Meanwhile, studies on the tumor cell cytotoxicity of ginsenosides have also increased over the years ([@B16]; [@B21]), for example, by activating apoptosis pathways or targeting NF-κB pathway to inhibit cell growth ([@B20]). Thus, it is largely unknown whether the tumor cell cytotoxic ginsenosides also inhibit normal cell growth and cause damage *in vivo*.

Human serum albumin (HSA), a product of liver, is an important component of blood ([@B14]). The concentration of HSA in human blood is about 40 mg/mL, accounting for 60% of the total protein content in blood ([@B15]). HSA has the functions of maintaining colloid osmotic pressure, stabilizing capillary membrane ([@B12]), anti-oxidation ([@B14]), and promoting blood circulation ([@B4]). Because of the structural characteristic of HSA, it can bind and transport a variety of substances, including cholesterol, fatty acids, hormones, bilirubin, and various anions. Our previous work has shown that HSA binds to ginsenoside Rh2(G-Rh2) and reduces its cytotoxicity ([@B9]). Here we show that HSA also binds to a series of anticancer cell ginsenosides including Rg3, Rg5, Rk1, and Rh4, which extracted from red ginseng, and the binding with HSA totally inhibited their cytotoxicity in HUVEC cells.

Materials and Methods {#s2}
=====================

Materials {#s2_1}
---------

Ginsenoside Rg3, Rg5, Rk1, Rh2, Rh4, and compound K were purchased from Sigma-Aldrich (≥98% HPLC, St. Louis, MO, USA). Recombinant human serum albumin was purchased from Healthgen Biltechnology Ltd. (Wuhan, China). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Fetal calf serum was purchased from Biological Industries (Kibbutz Beit-Haemerk, 25115, Israel). Dulbecco modified Eagle's medium (DMEM) was purchased from Gibco BRL (Grand Island, NE, USA). The following primary antibodies was used in this research:rabbit anti-PARP (Santa Cruz) and rabbit anti-cleaved caspase 3 (Cell-Signaling). The secondary antibody HRP-conjugated goat anti-rabbit IgG was purchased from Pierce (Thermal Scientific).HUVEC cells were obtained from the American Type Culture Collection (ATCC, Rockville, MA, USA).

Methods {#s2_2}
-------

### ITC Assay {#s2_2_1}

In this research, interaction between HSA and ginsenosides were identified with isothermal titration calorimetry on Malvern MicroCal ITC200. 40 μL HSA (400 μM) was titrated into 200 μL different ginsenosides (20 μM) in the sample cell independently. Data of titrations was collected by MicroCal ITC200 system (MAN0560-02-EN-00, May 2015), and MicroCal ITC-ORIGIN Analysis Software (MAN0577-02-EN-00, May 2015) was used for data processing. All the titrations were carried out at room temperature.

### Molecular Docking Analysis {#s2_2_2}

Molecular docking simulation were carried out by using AutoDock software (version 4.2.6) based on Lamarckian Genetic Algorithm (Scripps Research Institute, La Jolla, CA, USA) under default settings. Structures of ginsenosides were optimized by Chem3D 16.0 software to minimize their energy. Three-dimensional structure of ginsenosides were downloaded from NCBI Pubchem Compound database (Pubchem ID: Rg3, 9918693; Rg5, 1155001; Rk1, 11499198; Rh2, 119307; Rh4, 21599928.), and the crystal structure of human serum albumin was downloaded from RCSB Protein Data Bank (PDB ID: 1AO6). Results were optimized according to the empirical scoring function which estimates the binding free energy of the predicted complexes and visualized by PyMOL software (ver. 0.99, DeLano Scientific LLC).

### Cell Culture {#s2_2_3}

HUVEC cells were grown in DMEM with 10% v/v fatal calf serum, 100 μg/mL of streptomycin, and 100 U/mL of penicillin at 37°C in CO~2~ incubator with 5% CO~2~ in saturated humidity.

### Cell Viability Assay {#s2_2_4}

Exponentially growing HUVEC cells were resuspended in DMEM with 10% fetal calf serum and seeded into a 96-well plate at 1×10^4^ cells per well. After incubation at 37°C with 5% CO~2~, the culture medium were exchanged to DMEM without serum, then cells were treated with different ginsenosides in concentration from 0 to 50 μg/mL for 48 h in triplicate. At the 44th hour, 20 μL of MTT (5 mg/mL, Sigma) was added into each well, then incubated with cells for 4 h. All the culture medium were removed and 150 μL DMSO was added into each well to solubilize the formazan crystals formed by viable cells. Absorption at 550 nm of each well was measured with a microplate reader (TECAN, Maennedorf, Switzerland).

Statistical Analysis {#s2_3}
--------------------

Data were presented as mean ± standard deviation with Microsoft Office 2013 and imaged with Sigma plot 10 (Systat Software Inc., San Jose, CA). Statistical significance was calculated with Student's *t*-test. Differences were considered statistically significant as follow: \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001.

Results {#s3}
=======

HSA Interacts With a Series of Ginsenosides {#s3_1}
-------------------------------------------

Isothermal titration calorimetry (ITC) assay is a well-established method used in quantitative studies of biomolecule interactions. When the binding between protein and small molecular compound occurs, heat will be either absorbed or released. Heat transfer is measured by calorimeter during the titration, and this measuring enables accurate determination of binding constants, reaction stoichiometry, enthalpy, and entropy. In this study, we determined the interaction of ginsenoside Rg3, Rg5, Rk1, Rh4, and Rh2 (chemical structures showed in [**Figure 1**](#f1){ref-type="fig"}) with HSA by ITC. All the binding of these ginsenosides and HSA were endothermic, and the binding constant of ginsenoside Rg3, Rg5, Rk1, Rh4, and Rh2 with HSA was 3.25, 1.89, 6.04, 2.07, and 5.17×10^5^ M^−1^, respectively. Parameters of titration were shown in [**Figure 2**](#f2){ref-type="fig"}.

![Chemical structure of ginsenosides used in this study.](fphar-11-00498-g001){#f1}

![Results of isothermal titration calorimetry (ITC) assay. **(A)** (20S)G-Rg3. **(B)** G-Rg5. **(C)** G-Rk1. **(D)** (20S)G-Rh2. **(E)** G-Rh4.](fphar-11-00498-g002){#f2}

HSA Interact With Ginsenosides Through Different Binding Sites {#s3_2}
--------------------------------------------------------------

Next we investigated the molecular mechanism of the interaction between HSA and ginsenoside Rg3, Rg5, Rk1, Rh4, and Rh2 by molecular docking. 10 results obtained by using Autodock software in each simulation with different binding sites or conformations. In accordance with the binding constant from the ITC assay, we selected the solution closest to the real situation among all the results and analyzed key residues at the binding sites ([**Figure 3**](#f3){ref-type="fig"}).

![Molecular mechanisms of interactions between HSA and ginsenosides. **(A)** G-Rk1. **(B)** (20S)G-Rg3. **(C)** G-Rg5. **(D)** G-Rh4. **(E)** (20S)G-Rh2.](fphar-11-00498-g003){#f3}

Interestingly, even if these ginsenosides have similar chemical structures, each ginsenoside binds to different sites of HSA with different molecular forces, and Rg3, Rg5, Rh2, and Rh4 interact with HSA mainly by electrostatic interaction, while Rk1 interacts completely by hydrophobic interaction. Visualization of these results was shown in [**Figure 3**](#f3){ref-type="fig"}.

HSA Reduces the Cytotoxicity of Ginsenosides in HUVEC Cells {#s3_3}
-----------------------------------------------------------

In previous studies we have demonstrated that HSA and BSA reduced G-Rh2 cytotoxicity in human hepatoma HepG2 cells by binding to it. However, it is not clear whether cytotoxic ginsenosides make damage in HUVEC cells. We first examined the effect of ginsenosides used in ITC assay and compound K on cell viability of HUVEC cell by MTT assay. Results showed that all the 5 ginsenosides except Rh4 exhibit cell growth inhibitory effect in HUVEC cells which shown in [**Figure 4**](#f4){ref-type="fig"} and [**Table 1**](#T1){ref-type="table"}. To examine the HSA effect on the cytotoxicity of these ginsenosides in HUVEC cells, we determined cell viability at the presence of increasing concentrations of HSA. The results showed that HSA, even at low concentration (1.25 mg/ml) significantly reduced ginsenoside cytotoxicity in HUVEC cells ([**Figure 5**](#f5){ref-type="fig"}).

![Cell viability assay of HUVEC treated with ginsenosides Rg3, Rg5, Rk1, Rh4, Rh2, and Compound K.](fphar-11-00498-g004){#f4}

###### 

IC~50~ of different ginsenosides to HUVEC cells.

  Ginsenoside      (20S)G-Rg3       G-Rg5            G-Rk1            (20S)G-Rh2      G-Rh4   Compound K
  ---------------- ---------------- ---------------- ---------------- --------------- ------- ---------------
  IC~50~ (μg/ml)   19.576 ± 0.250   10.182 ± 0.292   12.272 ± 0.341   5.283 ± 0.048   --      4.107 ± 0.667

![HSA reduced the cytotoxicity of ginsenosides on HUVEC cells. Differences were considered statistically significant as follow: \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001.](fphar-11-00498-g005){#f5}

Discussion {#s4}
==========

Ginsenosides are the main active components of ginseng. In recent years, researchers have begun to study ginsenoside by means of cell biology, focusing on their functions of anti-inflammation, inhibiting tumor cell proliferation, migration, and activating apoptosis pathways. Most of these studies were conducted *in vitro*. In fact, when ginsenosides are ingested through diet, due to their poor bioavailability and easy degradation in the digestive tract, we cannot guarantee whether ginsenosides will be eventually transported to the places where they are needed. Previous studies have shown that some ginsenosides are absorbed by small intestinal villi through passive diffusion ([@B13]), and ginsenosides used in this study have a considerable bioavailability and stability *in vivo* ([@B27]). Here we demonstrated the interactions between 5 sort of ginsenosides from red ginseng and HSA by ITC and molecular docking. These results indicates that these ginsenosides were transported through the bloodstream to various parts of the body by binding with HSA after absorption by intestine, and also the interaction with HSA may result in the strong stabilities of these ginsenosides *in vivo* demonstrated in previous study ([@B27]).

Because of the cavities and depressions on the surface of HSA molecule, it can transport many substances by interacting with them. Amounts of drug molecules can bind to HSA reversibly, with binding constants ranging from 1×10^4^ to 1×10^6^ M^−1^ ([@B7]; [@B3]). In present study we found that ginsenosides with similar structures including ginsenoside Rg3, Rg5, Rk1, Rh4, and Rh2 can bind to HSA at different sites, indicating the binding with HSA might be a universal property of ginsenosides.

A number of *in vitro* studies have shown that ginsenoside Rg3, Rg5, Rk1, Rh2, and compound K lead to cell death in various tumor cells, generating a possibility that these reagents could be developed as new cancer drugs. As a drug candidate, it should not cause damage to vascular endothelia cells. Our previous study have shown that HSA even at a low concentration (1.68 mg/mL) effectively reduced cell viability by about 50% ([@B9]). However, only 0.625 mg/mL of HSA totally protected HUVEC cell damage induced by G-Rh2. These data suggested that tumor cells and normal cells might have different tolerance levels to ginsenosides, and it might be caused by different status between tumor cells and normal cells, such as differences in metabolic pathways, ROS levels ([@B10]), the expression level of ginsenoside-targeting proteins ([@B18]), and the integrity of apoptosis and/or autophagy signaling pathways. The possibility and the exact molecular and cellular mechanism that tumor cells are more sensitive to certain ginsenoside should be studied in future research.
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